Shashank Joshi Selected Research

saroglitazar

1/2016	A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.
2/2014	A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients having hypertriglyceridemia not controlled with atorvastatin therapy (PRESS VI).
1/2014	A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shashank Joshi Research Topics

Disease

7	COVID-19 08/2022 - 01/2021
6	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2014
4	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2014
3	Diabetes Mellitus 07/2022 - 08/2019
3	Insulin Resistance 01/2022 - 01/2016
3	Diabetes Complications 01/2022 - 04/2019
3	Hypertension (High Blood Pressure) 01/2022 - 11/2020
3	Body Weight (Weight, Body) 11/2021 - 01/2016
3	Hypertriglyceridemia 01/2016 - 01/2014
2	Infections 05/2022 - 01/2021
2	Hypoglycemia (Reactive Hypoglycemia) 11/2019 - 12/2018
1	Hyperinsulinism (Hyperinsulinemia) 05/2022
1	Headache (Headaches) 01/2022
1	Fatigue 01/2022
1	Mucormycosis 07/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Hemoglobinopathies 01/2021
1	Human Influenza (Influenza) 01/2021
1	Anemia 01/2021
1	Gingival Recession 01/2020
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 04/2019
1	Reproductive Tract Infections 04/2019
1	Disease Progression 12/2018
1	HIV-Associated Lipodystrophy Syndrome 01/2016
1	Obesity 09/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2015
1	Hematuria 09/2015
1	Neoplasms (Cancer) 09/2015
1	Diabetic Foot 05/2003
1	Ulcer 05/2003

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 01/2016
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 01/2014
3	Insulin (Novolin)FDA Link 12/2018 - 01/2016
3	saroglitazarIBA 01/2016 - 01/2014
2	LipidsIBA 05/2022 - 01/2016
2	TabletsIBA 05/2022 - 02/2014
2	favipiravirIBA 01/2022 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 07/2021 - 11/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 08/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 11/2019 - 08/2019
2	Pioglitazone (Actos)FDA Link 09/2015 - 01/2014
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 07/2022
1	MicronutrientsIBA 05/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2022
1	Promethazine (Promet)FDA LinkGeneric 05/2022
1	EnzymesIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	TRC150094IBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	InterferonsIBA 10/2021
1	Doxycycline (Periostat)FDA LinkGeneric 09/2021
1	Monoclonal AntibodiesIBA 07/2021
1	SteroidsIBA 07/2021
1	Lopinavir FDA Link 01/2021
1	umifenovirIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	CytokinesIBA 01/2021
1	empagliflozinIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	DiureticsIBA 11/2020
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2020
1	ThiazidesIBA 11/2020
1	Glucagon (Glukagon)FDA Link 01/2020
1	SodiumIBA 01/2020
1	CollagenIBA 01/2020
1	GlucocorticoidsIBA 12/2018
1	Insulin ReceptorIBA 12/2018
1	AntibodiesIBA 12/2018
1	Azathioprine (Imuran)FDA LinkGeneric 12/2018
1	C-PeptideIBA 01/2016
1	nuclear matrix protein 22IBA 09/2015
1	oxidized low density lipoproteinIBA 02/2014
1	Atorvastatin (Lipitor)FDA Link 02/2014
1	HDL CholesterolIBA 02/2014
1	LDL CholesterolIBA 02/2014
1	Tinidazole FDA Link 05/2003
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 05/2003

Therapy/Procedure

8	Therapeutics 08/2022 - 02/2014
5	Glycemic Control 05/2022 - 09/2015
1	Nutrition Therapy (Medical Nutrition Therapy) 11/2021
1	Surgical Amputation (Amputations) 04/2019